Literature DB >> 15471862

Limited redundancy of the proprotein convertase furin in mouse liver.

Anton J M Roebroek1, Neil A Taylor, Els Louagie, Ilse Pauli, Liesbeth Smeijers, An Snellinx, Annick Lauwers, Wim J M Van de Ven, Dieter Hartmann, John W M Creemers.   

Abstract

Furin is an endoprotease of the family of mammalian proprotein convertases and is involved in the activation of a large variety of regulatory proteins by cleavage at basic motifs. A large number of substrates have been attributed to furin on the basis of in vitro and ex vivo data. However, no physiological substrates have been confirmed directly in a mammalian model system, and early embryonic lethality of a furin knock-out mouse model has precluded in vivo verification of most candidate substrates. Here, we report the generation and characterization of an interferon inducible Mx-Cre/loxP furin knock-out mouse model. Induction resulted in near-complete ablation of the floxed fur exon in liver. In sharp contrast with the general furin knock-out mouse model, no obvious adverse effects were observed in the transgenic mice after induction. Histological analysis of the liver did not reveal any overt deviations from normal morphology. Analysis of candidate substrates in liver revealed complete redundancy for the processing of the insulin receptor. Variable degrees of redundancy were observed for the processing of albumin, alpha(5) integrin, lipoprotein receptor-related protein, vitronectin and alpha(1)-microglobulin/bikunin. None of the tested substrates displayed a complete block of processing. The absence of a severe phenotype raises the possibility of using furin as a local therapeutic target in the treatment of pathologies like cancer and viral infections, although the observed redundancy may require combination therapy or the development of a more broad spectrum convertase inhibitor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471862     DOI: 10.1074/jbc.M407152200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.

Authors:  Gero L Becker; Yinghui Lu; Kornelia Hardes; Boris Strehlow; Christine Levesque; Iris Lindberg; Kirsten Sandvig; Udo Bakowsky; Robert Day; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

2.  On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications.

Authors:  Frédéric Couture; François D'Anjou; Robert Day
Journal:  Biomol Concepts       Date:  2011-10-01

3.  Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon gamma.

Authors:  Marko Pesu; Linda Muul; Yuka Kanno; John J O'Shea
Journal:  Blood       Date:  2006-04-20       Impact factor: 22.113

4.  Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site.

Authors:  Lan Lin; Elizabeta Nemeth; Julia B Goodnough; Dharma R Thapa; Victoria Gabayan; Tomas Ganz
Journal:  Blood Cells Mol Dis       Date:  2007-09-14       Impact factor: 3.039

5.  Time for endothelial cell proprotein convertase PC5/6 in cardiovascular medicine?

Authors:  Jan Fritzsche; Philipp Stawowy
Journal:  J Mol Med (Berl)       Date:  2011-11       Impact factor: 4.599

6.  Identification of potent and compartment-selective small molecule furin inhibitors using cell-based assays.

Authors:  Bruno Ramos-Molina; Adam N Lick; Elias H Blanco; J Alejandro Posada-Salgado; Karina Martinez-Mayorga; Alan T Johnson; Guan-Sheng Jiao; Iris Lindberg
Journal:  Biochem Pharmacol       Date:  2015-05-21       Impact factor: 5.858

7.  Elongated and Shortened Peptidomimetic Inhibitors of the Proprotein Convertase Furin.

Authors:  Kornelia Hardes; Teodora Ivanova; Bastian Thaa; Gerald M McInerney; Tove Irene Klokk; Kirsten Sandvig; Sebastian Künzel; Iris Lindberg; Torsten Steinmetzer
Journal:  ChemMedChem       Date:  2017-04-04       Impact factor: 3.466

8.  Kinetics of albumin- and alpha-fetoprotein-production during rat liver development.

Authors:  Abderrahim Elmaouhoub; József Dudas; Giuliano Ramadori
Journal:  Histochem Cell Biol       Date:  2007-09-19       Impact factor: 4.304

9.  Role of proprotein convertases in prostate cancer progression.

Authors:  Frédéric Couture; François D'Anjou; Roxane Desjardins; François Boudreau; Robert Day
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

10.  The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model.

Authors:  Xiaowei Sun; Rachid Essalmani; Nabil G Seidah; Annik Prat
Journal:  Mol Cancer       Date:  2009-09-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.